HPV vaccine hesitancy among Chinese adults and its influencing factors in the context of improved vaccine accessibility - Takeaways - MDSpire

HPV vaccine hesitancy among Chinese adults and its influencing factors in the context of improved vaccine accessibility

  • By

  • Yanqiu Chen

  • Shiqi Xie

  • Jianrong Zhou

  • Hongjin Zhu

  • May 25, 2026

  • 0 min

Share

  • 1

    HPV vaccine hesitancy among adults in China is 19.86%, with higher rates in men (26.5%) compared to women (18.6%).

  • 2

    Key predictors of HPV vaccine hesitancy include higher complacency, lower confidence, and lower knowledge about HPV.

  • 3

    A cross-sectional survey of 967 adults revealed an average age of 33.41 years, with a majority being women (84.4%).

  • 4

    Despite improved vaccine accessibility and policies, HPV vaccination rates remain low, with only 6.21% of eligible women fully vaccinated in 2022.

  • 5

    Future public health strategies should focus on enhancing HPV knowledge and rebuilding vaccine confidence to reduce hesitancy.

Original Source(s)

HPV vaccine hesitancy among Chinese adults and its influencing factors in the context of improved vaccine accessibility

  • by Yanqiu Chen, Shiqi Xie, Jianrong Zhou, Hongjin Zhu

  • May 25, 2026

Related Content

‘Patient autonomy’ has nothing to do with childhood vaccine policies

Sustaining herd immunity against measles: Insights from a serological cohort study in an outbreak-free population

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis